trending Market Intelligence /marketintelligence/en/news-insights/trending/JSfXwN6yKSKRV2YAzwJhnQ2 content esgSubNav
In This List

Elite files abbreviated new drug application for pain reliever

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Elite files abbreviated new drug application for pain reliever

Elite Pharmaceuticals Inc. submitted an abbreviated new drug application to the U.S. FDA for a generic version of Norco, a pain relief drug.

According to IMS Health data, total annual U.S. sales for combination products of hydrocodone and acetaminophen are about $700 million.